1Yoshimura M, Yasue H, Okamura K, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 1993,87:464-469.
2Dickstein K. Natriuretic peptides in detection of heart failure. Lancet, 1997,351:3-4.
3Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol, 1998,274:H1684-H1689.
4Maeda K, Takayoshi T, Wada T, et al. Palsma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J, 1998,135:825-832.
5Clerio A, Lervasi G, Chicca M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest, 1998,21:170-179.
6Maisel A. B-type natriuretic peptide levels: a potential novel "hite count" for congestive heart failure. J Cardiac Fail, 2001,7:183-193.
7Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.J Am Coll Cardiol,2002,39:202-209.
8Abraham WT,Lowes BD,Ferguson DA,et al.Systemic hemodynamic,neurohormonal,and renal excretory effects of a steady-state infusion of human brain natriuretic peptide in patients with decompensated chronic heart failure.J Card Fail,1998,4:37-44.
9Mills RM,LeJemtel TH,Horton DP,et al.Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure:a randomized,double-blind,placebo-controlled clinical trial.Natrecor Study Group.J Am Coll Cardiol,1999,34:155-162.
10Colucci WS,Elkayam E,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated heart failure.N Engl J Med,2000,343:246-253.
